ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation

Ruth Jessen Hickman, MD  |  Issue: December 2025  |  November 14, 2025

According to Dr. Manek, the broad, rapidly changing field of the microbiome can be distilled into one clinically actionable point: Anything that increases butyrate helps fight inflammation. To build butyrate, she emphasized pairing probiotic/fermented foods with prebiotic fibers—two strategies that work hand in hand. Her preference isn’t a capsule, but whole, naturally fermented foods. Whole foods, such as fruits and vegetables, are also rich in prebiotic components that help promote a healthy microbiome. In contrast, ultra-processed foods may have a detrimental effect on overall gut microbiome health.6 She recommended the International Scientific Association for Prebiotics and Probiotics as a trusted source for emerging scientific information.7

Food Avoidance Trials

Some patients may also benefit from cutting out other specific types of foods, like those containing gluten, Dr. Manek argued, because they may have an inflammatory effect. This science is not settled, with many experts claiming a lack of convincing evidence on this point, at least for patients without celiac disease or a clear gluten intolerance.8,9 For some, a gluten-free diet may entail eating fewer ultra-processed foods, which can complicate interpretation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

If patients do want to try a dietary change, such as going gluten-free, Dr. Manek recommends a 12-week trial, carefully comparing symptoms, such as joint aching, and frequency of pain reliever use (e.g., NSAIDs) before and after the change.

Supplements

Although a huge part of the commercial health industry, supplements raise concerns about drug interactions, product quality and efficacy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Especially for complex patients on multiple medications, it’s important to assess safety and potential drug interactions. Dr. Manek noted that Natural Medicine’s Database for Healthcare Professions, a subscription-based service, is a helpful resource for clinicians in this respect.10

To address a frequently asked question of which brand of a supplement to choose, Dr. Manek recommends consumerlab.com as a subscription-based, patient resource. They perform third-party testing of popular supplement brands, assessing quality and giving price comparisons.

Vitamin D

Vitamin D plays an important role in immunomodulation, and many patients do not obtain sufficient levels through sunlight and diet alone. Multiple studies have shown associations between low levels of vitamin D and the presence and severity of rheumatic diseases.11

The optimal level of serum vitamin D is a matter of debate. Although a level greater than 30 ng/mL may prevent osteomalacia and secondary osteoporosis, higher levels might be needed for overall immune and general health.11

Dr. Manek tests her patients for vitamin D and very frequently finds levels below normal. She has found that many patients with immune diseases get better control of inflammation with vitamin D supplementation. She aims for 50 to 80 ng/mL.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAComplementary and Alternative TherapiesDietstress managementsupplements

Related Articles

    Drug Updates

    November 1, 2009

    Information on News Approvals and Medication Safety

    What Diet to Recommend to Patients with Rheumatoid Arthritis?

    November 1, 2013

    With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

    Diet May Help Reduce Inflammation in RA

    March 27, 2023

    In a small study, an anti-inflammatory diet helped reduce pain and swelling in a subset of people with rheumatoid arthritis (RA). Diet changes are complementary to standard treatment. Diet-related research can be challenging, but many patients with RA are motivated to try healthy changes.

    2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response

    March 15, 2016

    SAN FRANCISCO—Inflammation can be either acute or chronic, and it’s the inflammatory responses that don’t shut down normally, or resolve, that cause tissue damage in rheumatic disease. “Resolution bridges the gap between acute inflammation and adaptive immunity,” said Derek W. Gilroy, PhD, head of the Centre for Clinical Pharmacology and Professor of Immunology at University…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences